Prakash Gaba of prakashgaba.com is of the view that one may stay invested in Venus Remedies.
Gaurang Shah of Geojit Financial Services is of the view that one may prefer Granules India.
Aurobindo Pharma | TCS | Idea Cellular | Bharti Airtel | Jyothy Labs | Swan Energy | Infibeam | Hindustan Organic | Asian Oilfield | SRS | Shriram EPC | Jyoti Structures | Baba Arts and Coffee Day are stocks, which are in the news today.
Hero Motocorp | Lupin | Cipla | Bank of India | eClerx Services | Ratnamani Metals | Healthcare Global | Reliance Power | Union Bank | Thermax | Indraprastha Gas | Adani Transmission | Kotak Mahindra Bank | Axis Bank and Idea Cellular are stocks, which are in the news today.
Sun Pharma | Tata Steel | Cipla | Emkay Global | FDC | Bosch | Dhampur Sugar | Parag Milk | Narayana Hrudayalaya | IG Petro | Snowman Logistics | Jamna Auto | Caplin Point | Power Grid | Ramco Systems | UCO Bank | TBZ | Apollo Tyres and Tata Global are stocks, which are in the news today.
Bank of Baroda | Tata Sponge Iron | Bharti Airtel | Zuari Agro | Tata Power | Venus Remedies | Pricol | ARSS Infrastructure | Indian Overseas Bank | Patel Engineering | Nutraplus | Alkem Labs | Parag Milk Foods | Glenmark Pharmaceuticals | Aban Offshore | JB Chemicalss and Bajaj Finserv are stocks, which are in the news today.
SP Tulsian of sptulsian.com, in an interview to CNBC-TV18, gave his views on various stocks.
SBI | Tata Motors | HUL | Bharti Airtel | Cipla | ACC | Ambuja Cements | Emami | NHPC | Aurobindo Pharma | Visa Steel | Ruchi Soya | Venus Remedies | Financial Technologies | Tata Global | BL Kashyap | Asahi India Glass | IVRCL | Alstom T&D India | GSK Pharma and Capital First are stocks, which are in the news today.
Prakash Diwan of Altamount Capital Management is of the view that one may prefer Suven Life Sciences.
Wipro | DLF | Suzlon Energy | Larsen and Toubro | Tata Power | Jaiprakash Associates | BHEL | Adani Enterprises | GMR Infra | SREI Infra | Eros International | NBCC | ACC | Asian Paints | Jain Irrigation | MM Forgings | Capital First | Precision Wires | JK Paper | 3i Infotech | ENIL | CARE Ratings and NALCO are stocks, which are in the news today.
Pharmaceutical firm Venus Remedies Ltd, today said it has received Indian product patent for its antibiotic research product Vancoplus. The Indian Patent Office (IPO) granted the licence which is valid till 2025, said Venus.
Here are top 10 stocks to watch on Sep 17 - Bharti Airtel, Maruti, Sun Pharma, Lupin, Cipla, Venus Remedies, JSW Steel, Future Retail, GMR Infra and Union Bank.
Watch the interview of Vishal Malkan, CMT at malkansview.com and Lancelot D'Cunha, CEO of ITI Wealth Management Pvt Ltd with Reema Tendulkar & Sumaira Abidi on CNBC-TV18, in which they spoke about specific stocks and sectors.
Lancelot D'Cunha, CEO at ITI Wealth management is of the view that one may exit Venus Remedies.
Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have Piramal Enterprises, Rain Industries, Mirza International, Ashapura, Ind-Swift Laboratories, Venus Remedies, Yes Bank, Eros International, Indian Oil Corporation (IOC) and Bharat Petroleum Corporation (BPCL).
The house continues to remain positive on oil marketing companies on back of expected reforms and disinvestments. The reduction in crude prices has been an added advantage says Sinha.
Venus Remedies stretched liquidity is on account of the significant increase in total cost of the large debt-funded capital expenditure over the past one year and high working capital requirements. The company is undertaking capex towards setting up marketing office.
Manav Chopra of Nirmal Bang recommends buying Biocon for a target price of Rs 520 and Venus Remedies for a target price of Rs 370.
Dharmesh Kant, IndiaNivesh Securities Private Limited advises buying Tamil Nadu Newsprint and Papers for a target price of Rs 172 and Pratibha Industries for a target price of Rs 73.
Here are few top buzzing stocks picked by CNBC-TV18's analysts in trade today. We have Punj Lloyd, ONGC, Oil India Opto Circuit, Tata Steel, Poly Medicure, TCI, Venus Remedies, Wockhardt, Bliss GVS Pharma and TVS Electronics.
"This deal with Mylan, the world's third largest generic drug manufacturer, will enable Venus to market meropenem in Denmark, Sweden and Finland for a period of five years," said the company in its filing.
ITC | Cipla | MTNL | Maruti Suzuki | Bharti Airtel | Lupin | Tree House | Radha Madhav Corporation | NTPC | Hathway Cable | GE Shipping | Sesa Sterlite | Era Infra | SKS Microfinance and Deepak Fertilisers are stocks, which are in the news today.
Venus Remedies will be initially manufacturing the drug at the Venus Medicine Research Centre, its research unit, for assisting Teva in registrations.